Norfloxacin For Hepatopulmonary Syndrome: A Pilot Study of a Rare Disease

Norfloxacin For Hepatopulmonary Syndrome: A Pilot Study of a Rare Disease Samir Gupta, Masters of Science, 2008 Graduate Department of Health Policy, Management and Evaluation University of Toronto Introduction: Hepatopulmonary Syndrome is a rare disease characterized by abnormal gas-exchange an...

Full description

Bibliographic Details
Main Author: Gupta, Samir
Other Authors: Bayoumi, Ahmed
Format: Others
Language:en_ca
Published: 2008
Subjects:
Online Access:http://hdl.handle.net/1807/10431